Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hereditary Sensory and Autonomic Neuropathies × Pharmaceutical Preparations × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 2 Rare Malignant Neoplasm 1 Myeloproliferative Disorders 1 Melanoma 1 Immunoglobulin Light-chain Amyloidosis 1 Hereditary Sensory and Autonomic Neuropathies 1 Hepatitis B 1 Dysplastic Nevus Syndrome 1 Complicated Adrenal Tumor Diseases 1 Colorectal Adenocarcinoma 1 Brain Neoplasms 1

Interventions

pembrolizumab 1 Pharmaceutical Preparations 1 Nivolumab 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06599619 2026-01-26

Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi

University of Pittsburgh

Dysplastic Nevus Syndrome, Melanoma, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡